FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Moriarty Thomas M 2. Issuer Name and Ticker or Trading Symbol CVS HEALTH Corp [ CVS ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
EVP & General Counsel
(Last)         (First)         (Middle)
ONE CVS DRIVE
3. Date of Earliest Transaction (MM/DD/YYYY)
5/4/2021
(Street)
WOONSOCKET, RI 02895
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  5/4/2021    M    49279  A $58.34  49279  D   
Common Stock                 81179.0221  I  By GRAT 
Common Stock (restricted)                 8008  D   
Stock Unit                 45747.7872  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option  $58.34 (1) 5/4/2021    M        49279   4/1/2021 (2) 4/1/2030  Common Stock  49279  $0  147837  D   
Stock Option  $102.26                  4/1/2016 (3) 4/1/2022  Common Stock  51361    51361  D   
Stock Option  $104.82                  4/1/2017 (4) 4/1/2023  Common Stock  71696    71696  D   
Stock Option  $78.05                  4/3/2018 (5) 4/3/2024  Common Stock  125224    125224  D   
Stock Option  $62.21                  4/1/2019 (6) 4/1/2025  Common Stock  145959    145959  D   
Stock Option  $54.19                  4/1/2020 (7) 4/1/2029  Common Stock  101004    101004  D   
Stock Option  $74.30                  4/1/2022 (8) 4/1/2031  Common Stock  155495    155495  D   

Explanation of Responses:
(1)  The number of shares subject to the option were calculated using a 30-day average price.
(2)  Option became exercisable in four equal annual installments, commencing 4/1/2021.
(3)  Option became exercisable in four equal annual installments, commencing 4/1/2016.
(4)  Option became exercisable in four equal annual installments, commencing 4/1/2017.
(5)  Option became exercisable in four equal annual installments, commencing 4/3/2018.
(6)  Option became exercisable in four equal annual installments, commencing 4/1/2019.
(7)  Option became exercisable in four equal annual installments, commencing 4/1/2020.
(8)  Option becomes exercisable in four equal installments, commencing 4/1/2022.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Moriarty Thomas M
ONE CVS DRIVE
WOONSOCKET, RI 02895


EVP & General Counsel

Signatures
/s/ Thomas M. Moriarty 5/6/2021
**Signature of Reporting Person Date
CVS Health (NYSE:CVS)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more CVS Health Charts.
CVS Health (NYSE:CVS)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more CVS Health Charts.